Basit öğe kaydını göster

Outcomes of low-dose valproic acid treatment in patients with juvenile myoclonic epilepsy

dc.contributor.authorAydin, Senay
dc.contributor.authorOzkara, Cigdem
dc.contributor.authorGurer, Reyhan
dc.date.accessioned2021-03-05T19:21:17Z
dc.date.available2021-03-05T19:21:17Z
dc.identifier.citationGurer R., Aydin S., Ozkara C., "Outcomes of low-dose valproic acid treatment in patients with juvenile myoclonic epilepsy", SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, cilt.70, ss.43-48, 2019
dc.identifier.issn1059-1311
dc.identifier.othervv_1032021
dc.identifier.otherav_cee0c174-f887-402b-a398-579e5f6c6d2d
dc.identifier.urihttp://hdl.handle.net/20.500.12627/136842
dc.identifier.urihttps://doi.org/10.1016/j.seizure.2019.06.021
dc.description.abstractPurpose: There are conflicting data regarding the drug dose that is sufficient to achieve seizure control as well as the parameters of seizure remission in juvenile myoclonic epilepsy (JME). The present study aimed to identify factors that contribute to seizure control in JME and to evaluate factors associated with JME remission and the efficacy of low-dose valproic acid (VPA) therapy.
dc.language.isoeng
dc.subjectKlinik Tıp (MED)
dc.subjectDahili Tıp Bilimleri
dc.subjectYaşam Bilimleri
dc.subjectTemel Bilimler
dc.subjectKLİNİK NEUROLOJİ
dc.subjectKlinik Tıp
dc.subjectSağlık Bilimleri
dc.subjectNEUROSCIENCES
dc.subjectSinirbilim ve Davranış
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectTıp
dc.subjectNöroloji
dc.titleOutcomes of low-dose valproic acid treatment in patients with juvenile myoclonic epilepsy
dc.typeMakale
dc.relation.journalSEIZURE-EUROPEAN JOURNAL OF EPILEPSY
dc.contributor.departmentIstanbul Haydarpasa Numune Training & Research Hospital , ,
dc.identifier.volume70
dc.identifier.startpage43
dc.identifier.endpage48
dc.contributor.firstauthorID266578


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster